We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

1,575 hedge funds and large institutions have $73.2B invested in Gilead Sciences in 2017 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 535 increasing their positions, 691 reducing their positions, and 116 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 202 | Existing positions closed: 116

5% more funds holding

Funds holding: 1,504 → 1,575 (+71)

1.25% more ownership

Funds ownership: 76.99% → 78.25% (+1.3%)

10% less capital invested

Capital invested by funds: $81.5B → $73.2B (-$8.37B)

23% less repeat investments, than reductions

Existing positions increased: 535 | Existing positions reduced: 691

40% less call options, than puts

Call options by funds: $1.57B | Put options by funds: $2.63B

46% less funds holding in top 10

Funds holding in top 10: 96 → 52 (-44)

Holders
1,575
Holders Change
+71
Holders Change %
+4.72%
% of All Funds
35.71%
Holding in Top 10
52
Holding in Top 10 Change
-44
Holding in Top 10 Change %
-45.83%
% of All Funds
1.18%
New
202
Increased
535
Reduced
691
Closed
116
Calls
$1.57B
Puts
$2.63B
Net Calls
-$1.06B
Net Calls Change
-$328M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$794M
2
Capital World Investors
Capital World Investors
California
+$529M
3
Dodge & Cox
Dodge & Cox
California
+$418M
4
Sanders Capital
Sanders Capital
Florida
+$382M
5
CGI
CI Global Investments
California
+$275M

Top Sellers

Rank Fund Capital Flow
1
CWG
C WorldWide Group
Denmark
-$300M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$273M
3
Renaissance Technologies
Renaissance Technologies
New York
-$202M
4
Boston Partners
Boston Partners
Massachusetts
-$201M
5
Bank of America
Bank of America
North Carolina
-$194M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1101
Close Asset Management
United Kingdom
$609K – – –
FM
1102
Foster & Motley
Ohio
$607K -$8.2K -108 -1%
FAIM
1103
Financial Advocates Investment Management
Washington
$607K +$644K +8,477 New
TCOO
1104
Trust Company of Oklahoma
Oklahoma
$606K -$20.5K -270 -3%
BCM
1105
Brown Capital Management
Maryland
$602K -$61.2K -806 -9%
SC
1106
SouthState Corp
Florida
$601K -$185K -2,442 -23%
CSS
1107
Cubist Systematic Strategies
Connecticut
$600K -$1.11M -14,589 -64%
TB
1108
Terril Brothers
Missouri
$600K -$30.4K -400 -5%
BST
1109
Bath Savings Trust
Maine
$600K +$7.21K +95 +1%
GC
1110
Garde Capital
Washington
$597K – – –
ARMT
1111
Amica Retiree Medical Trust
Rhode Island
$595K – – –
AF
1112
Advisornet Financial
Minnesota
$594K +$630K +8,297 New
AAM
1113
Auxier Asset Management
Oregon
$593K +$11.4K +150 +2%
GWM
1114
Greenwich Wealth Management
Connecticut
$589K -$23.1K -304 -4%
TC
1115
Telemus Capital
Michigan
$589K +$624K +8,221 New
GI
1116
GS Investments
Minnesota
$584K – – –
AWP
1117
Ascent Wealth Partners
New York
$582K +$1.52K +20 +0.2%
JT
1118
Jump Trading
Illinois
$582K +$616K +8,117 New
VCA
1119
Verdence Capital Advisors
Maryland
$582K +$617K +8,125 New
FHA
1120
Flagship Harbor Advisors
Massachusetts
$581K -$64.5K -850 -10%
T
1121
TOBAM
France
$581K -$24.4K -321 -4%
PHIMC
1122
Private Harbour Investment Management & Counsel
Ohio
$578K – – –
MA
1123
MANA Advisors
New York
$577K +$611K +8,051 New
Jennison Associates
1124
Jennison Associates
New York
$576K -$1.21M -15,969 -67%
VOAM
1125
Vertex One Asset Management
British Columbia, Canada
$573K – – –
43 44
45
46 47

GILD Hedge Fund Activity: Q4 2017 in Review

1,575 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2017, worth a combined $73.2B — down 10% from $81.5B a quarter earlier.

Buyers outnumbered sellers: 202 funds opened new GILD positions and 116 closed out — a net gain of 86 holders — while 535 added to existing stakes and 691 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $794M. The largest seller was C WorldWide Group, cutting an estimated $300M.

  • 1,575 institutional investors held Gilead Sciences (GILD) as of Q4 2017, up from 1,504 in Q3 2017.
  • Funds reported $73.2B of Gilead Sciences stock for Q4 2017, down 10% quarter-over-quarter.
  • 202 funds opened new Gilead Sciences positions in Q4 2017 and 116 closed out, a net change of +86 holders.
  • The largest Gilead Sciences buyer in Q4 2017 was Capital Research Global Investors, an estimated $794M added.
  • The largest Gilead Sciences seller in Q4 2017 was C WorldWide Group, an estimated $300M sold.

Based on aggregated 13F filings for Q4 2017.